相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Terpenes in Cannabis sativa - From plant genome to humans
Judith K. Booth et al.
PLANT SCIENCE (2019)
COPD, emphysema and the onset of lung cancer. A systematic review
Cecilia Mouronte-Roibas et al.
CANCER LETTERS (2016)
WIN 55,212-2 Inhibits the Epithelial Mesenchymal Transition of Gastric Cancer Cells via COX-2 Signals
Xiangshu Xian et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non-small cell lung cancer by downregulation of EGFR pathway
Janani Ravi et al.
MOLECULAR CARCINOGENESIS (2016)
Endocannabinoid system as a regulator of tumor cell malignancy - biological pathways and clinical significance
Maria Pyszniak et al.
ONCOTARGETS AND THERAPY (2016)
Non-small cell lung cancer: current treatment and future advances
Cecilia Zappa et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
Cardamonin Suppresses TGF-beta 1-Induced Epithelial Mesenchymal Transition via Restoring Protein Phosphatase 2A Expression
Eun Ji Kim et al.
BIOMOLECULES & THERAPEUTICS (2015)
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
Sean D. McAllister et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2015)
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer
Mohamad Elbaz et al.
MOLECULAR ONCOLOGY (2015)
Increased CB2 mRNA and anandamide in human blood after cessation of cannabis abuse
Daniela Muhl et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2014)
FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway
Janani Ravi et al.
ONCOTARGET (2014)
Cannabidiol as potential anticancer drug
Paola Massi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Association between Cannabinoid CB1 Receptor Expression and Akt Signalling in Prostate Cancer
Mariateresa Cipriano et al.
PLOS ONE (2013)
The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice
Bogna M. Ignatowska-Jankowska et al.
PSYCHOPHARMACOLOGY (2013)
Expression of the cannabinoid type I receptor and prognosis following surgery in colorectal cancer
Chan Kwon Jung et al.
ONCOLOGY LETTERS (2013)
TGF-β-induced epithelial-mesenchymal transition of A549 lung adenocarcinoma cells is enhanced by pro-inflammatory cytokines derived from RAW 264.7 macrophage cells
Mikiko Kawata et al.
JOURNAL OF BIOCHEMISTRY (2012)
Towards the use of cannabinoids as antitumour agents
Guillermo Velasco et al.
NATURE REVIEWS CANCER (2012)
The endocannabinoid system and cancer: therapeutic implication
Josee Guindon et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Cannabinoids, endocannabinoids, and cancer
Daniel J. Hermanson et al.
CANCER AND METASTASIS REVIEWS (2011)
Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non-Small Cell Lung Cancer Growth and Metastasis
Anju Preet et al.
CANCER PREVENTION RESEARCH (2011)
PAX3-FOXO1 Induces Cannabinoid Receptor 1 to Enhance Cell Invasion and Metastasis
Amy D. Marshall et al.
CANCER RESEARCH (2011)
A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma
Sofia Torres et al.
MOLECULAR CANCER THERAPEUTICS (2011)
High Tumour Cannabinoid CB1 Receptor Immunoreactivity Negatively Impacts Disease-Specific Survival in Stage II Microsatellite Stable Colorectal Cancer
Sofia B. Gustafsson et al.
PLOS ONE (2011)
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
P. Pacher et al.
PROGRESS IN LIPID RESEARCH (2011)
Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas
Maider Lopez De Jesus et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
Tumour Cannabinoid CB1 Receptor and Phosphorylated Epidermal Growth Factor Receptor Expression Are Additive Prognostic Markers for Prostate Cancer
Christopher J. Fowler et al.
PLOS ONE (2010)
A high cannabinoid CB1 receptor immunoreactivity is associated with disease severity and outcome in prostate cancer
Sui Chu Chung et al.
EUROPEAN JOURNAL OF CANCER (2009)
Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Δ9-tetrahydrocannabinol
Robert E. Vann et al.
DRUG AND ALCOHOL DEPENDENCE (2008)
Cannabinoids in pancreatic cancer:: Correlation with survival and pain
Christoph W. Michalski et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
The international epidemiology of lung cancer - Geographical distribution and secular trends
Danny R. Youlden et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Δ9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo
A. Preet et al.
ONCOGENE (2008)
Transtorming growth factor β1 induces epithelial-to-mesenchymcl transition of A549 cells
Ju Hee Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2007)
Snail, ZEB and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
Hector Peinado et al.
NATURE REVIEWS CANCER (2007)
Distinctive pattern of cannabinoid receptor type II (CB2) expression in adult and pediatric brain tumors
Aleksandra Ellert-Miklaszewska et al.
BRAIN RESEARCH (2007)
Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma
Xundi Xu et al.
CANCER GENETICS AND CYTOGENETICS (2006)
Cannabinoids and cancer: pros and cons of an antitumour strategy
Maurizio Bifulco et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism
A Vaccani et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Phosphodiesterase 4 inhibition decreases MUC5AC expression induced by epidermal growth factor in human airway epithelial cells
M Mata et al.
THORAX (2005)
Epidermal growth factor receptor family in lung cancer and premalignancy
WA Franklin et al.
SEMINARS IN ONCOLOGY (2002)
Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth
M Bifulco et al.
FASEB JOURNAL (2001)
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
T Bisogno et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Neuropharmacology and therapeutic potential of cannabinoids
RG Pertwee
ADDICTION BIOLOGY (2000)
分享论文
